Authors: Koussa, S Megarbane, A Rizk, T Tamraz, J Chemaly, R

Citation: S. Koussa et al., Frontal pseudo-tumoral form of adrenoleukodystrophy, REV NEUROL, 156(11), 2000, pp. 1017-1019

Authors: Paty, DW Hartung, HP Ebers, GC SoelbergSorensen, P Abramsky, O Kesselring, J Delwel, GO Miller, A Korczyn, AD Flechter, S Milo, R Levic, Z Pantovic, M Guseo, A Csiba, L Komoly, S Havrdova, E Urbanek, K Traubner, P Selmaj, K Czlonkowska, A Milonas, I Karageorgiou, K Sfaggos, G Siva, A Karabudak, R Eraksoy, M Idiman, E Brinar, V Demarin, V Ibrahim, IAS Hashem, S Chemaly, R Atweh, S Bohlega, SAI Boiko, A

Citation: Dw. Paty et al., Management of relapsing-remitting multiple sclerosis: diagnosis and treatment guidelines (vol 6, pg S1, 1999), EUR J NEUR, 6(6), 1999, pp. NIL_2-NIL_2

Authors: Baghdiguian, S Martin, M Richard, I Pons, F Astier, C Bourg, N Hay, RT Chemaly, R Halaby, G Loiselet, J Anderson, LVB de Munain, AL Fardeau, M Mangeat, P Beckmann, JS Lefranc, G

Citation: S. Baghdiguian et al., Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkBa/NF-kB pathway in limb-girdle muscular dystrophy type 2A (vol 5, pg 503, 1999), NAT MED, 5(7), 1999, pp. 849-849

Authors: Baghdiguian, S Martin, M Richard, I Pons, F Astier, C Bourg, N Hay, RT Chemaly, R Halaby, G Loiselet, J Anderson, LVB de Munain, AL Fardeau, M Mangeat, P Beckmann, JS Lefranc, G

Citation: S. Baghdiguian et al., Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the I kappa B alpha/NF-kappa B pathway in limb-girdle muscular dystrophy type 2A, NAT MED, 5(5), 1999, pp. 503-511

Authors: Medlej, R Allawe, A Chemaly, R Halaby, G

Citation: R. Medlej et al., Calcified malignant insulinoma - A case report, ENDOCRINOLO, 9(1), 1999, pp. 57-60

Authors: Huang, YW Hamilton, A Arnuk, OJ Chaftari, P Chemaly, R

Citation: Yw. Huang et al., Current drug therapy for multiple myeloma, DRUGS, 57(4), 1999, pp. 485-506